Monkeys, demented by genetic engineering, should help in the search for Alzheimer’s drugs!!
The notifying parties argue that the number of patients is increasing rapidly. But patent critics do not want to condone such practices.
A patent on monkeys and other animals in which symptoms of Alzheimer’s disease are triggered by genetic engineering causes protests among patent opponents.
It protects rodents, primates, and great apes, which are specifically made demented for research in the pharmaceutical industry and then used as laboratory animals.
The organization Testbiotech announced that opposition has now been filed against the patent.
The European Patent Office (EPO) confirmed receipt of the opposition.
“The patented process is associated with considerable suffering for the animals – the specific medical benefit, on the other hand, seems questionable”, said Christoph Then from Testbiotech.
There are ethical concerns.
Last but not least, such patents could create economic incentives for unnecessary animal…
View original post 279 more words